|
|
Thomson Financial Business Description:
| The Group's principal activity is to develop, manufacture and market pharmaceutical products for unmet medical needs in both niche and broader markets segments. Its products are distributed worldwide through a direct sales force in the United States. The Group products are Oxandrin & oxandrolone .Oxandrin is an oral synthetic derivative of testosterone used to promote weight gain following involuntary weight loss related to disease or medical condition. Oxandrin is indicated in the United States as adjunctive therapy to promote weight gain after weight loss following extensive surgery, chronic infections, or severe trauma. The Oral Liquid Pharmaceutical products include formulations of tamoxifen, dipyridamole, furosemide, dexamethasone, methadone and folic acid. The brand names include Tev-Tropin, Growject, Zomacton and Bio-Tropin. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Savient Pharmaceuticals Inc
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
